Who invested in Aldatu Biosciences

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$3.0Mraised across 1 round since 2024, from 1 source

Latest round: Grant, $3.0MAug 2024
Investors: 3

See who backed them

The rounds

Aug 2024
Grant$3.0M
Source recorded

Founders and team

From Aldatu Biosciences's own website and the SEC filings it signed: 5 on the team.

Mike HenryChief Business Officer
Betsy Wonderly TrainorVP Development
Larry CarrascoVP Operations
David M. RaiserExecutive Officer, Directori
Iain J. MacleodExecutive Officer, Directori

Everyone who backed them

MassChallengeAccelerator1round

National Institutes of HealthGovernment1round

National Institute of Allergy and Infectious DiseasesInvestment firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Aldatu Biosciences

Who invested in Aldatu Biosciences?

Aldatu Biosciences's investors include MassChallenge, National Institutes of Health and National Institute of Allergy and Infectious Diseases.

How much has Aldatu Biosciences raised?

Aldatu Biosciences has raised $3.0M across 1 round since 2024.

When did Aldatu Biosciences last raise?

Aldatu Biosciences's most recent round was a Grant of $3.0M in Aug 2024.

What was Aldatu Biosciences's biggest round?

Its most recent round, $3.0M in Aug 2024, is also its largest on record.

Who backed Aldatu Biosciences first?

Aldatu Biosciences's first round on record, in Aug 2024, was backed by MassChallenge, National Institutes of Health and National Institute of Allergy and Infectious Diseases.